Secondary pulmonary hypertension - Diagnosis and management

European Review for Medical and Pharmacological Sciences

Volumn 9, Issue 6, 2005, Pages 331-342

  Carbone, R ^a   Bossone, E ^b   Bottino, G ^a   Monselise, A ^c   Rubenfire, M ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cardiopulmonary testing; Diagnosis; Pulmonary hypertension; Therapy

Indexed keywords

ANTICOAGULANT AGENT; BERAPROST; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIURETIC AGENT; FIBRINOLYTIC AGENT; ILOPROST; LOOP DIURETIC AGENT; NITRIC OXIDE; OXYGEN; POTASSIUM SPARING DIURETIC AGENT; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE; RADIOISOTOPE; VASODILATOR AGENT;

AEROSOL; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONNECTIVE TISSUE DISEASE; COR PULMONALE; COST EFFECTIVENESS ANALYSIS; DOPPLER ECHOGRAPHY; DRUG DELIVERY SYSTEM; ENDARTERECTOMY; EXERCISE; HEART LEFT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HUMAN; HYPOTENSION; HYPOXEMIA; INTERSTITIAL LUNG DISEASE; LUNG ANGIOGRAPHY; LUNG EMBOLISM; LUNG PARENCHYMA; LUNG VENTILATION PERFUSION RATIO; LUNG WEDGE PRESSURE; MITRAL VALVE DISEASE; NUTRITIONAL SUPPORT; OXYGEN SATURATION; PATHOPHYSIOLOGY; PROGNOSIS; PULMONARY ARTERY OCCLUSION; PULMONARY HYPERTENSION; QUANTITATIVE ANALYSIS; REVIEW; THROMBOEMBOLISM;

HEART; HUMANS; HYPERTENSION, PULMONARY; LUNG;

EID: 31844449771     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Fishman AP. Pulmonary hypertension and cor pulmonale. In: Fishman AP (ed): Pulmonary Diseases and Disorders. McGraw-Hill, New York, 1998, vol 83, pp 1261-1296.
2. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 1987; 107: 216-223.
3. Ricciardi MJ, Rubenfire M. How to manage secondary pulmonary hypertension. Recognizing and treating cor pulmonale and chronic thromboembolism. Postgrad Med 1999; 105: 183-190.
4. Eysmann SB, Palevsky HI, Reichek N, et al. Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension. Circulation 1989; 80: 353-360.
5. Raymond RJ, Hinderliter AL, Willis PW, et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol 2002; 39: 1214-1219.
6. Tei C, Dujardin KS, Hodge DO, et al. Doppler echocardiographic index for assessment of global right ventricular function. J Am Soc Echocardiogr 1996; 9: 838-847.
7. Yeo TC, Dujardin KS, Tei C, et al. Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension. Am J Cardiol 1998; 81: 1157-1161.
8. Schaufelberger M, Swedberg K. Is 6-minute walk test of value in congestive heart failure? Am Heart J 1998; 136: 371-372.
9. Paciocco G, Martinez FJ, Bossone E, Pielsticker E, Gillespie B, Rubenfire M. Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension. Eur Respir J 2001; 17: 647-652.
10. Miyamoto S, Nagaya N, Satoh T, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000; 161: 487-492.
11. Lucas C, Warner Stevenson L, Johnson W, et al. The 6-min walk and peak oxygen consumption in advanced heart failure: aerobic capacity and survival. Am Heart J 1999; 138: 618-624.
12. Sciurba F, Slivka W. Six-minute walk testing. Semin Resp and Crit Care Med 1998; 19: 383-392.
13. Bishop JM, Cross KW. Physiologic variables and mortality in patients with various categories of chronic respiratory disease. Bull Eur Physiopath Respir 1984; 20: 495-500.
14. Traver GA, Cline MG, Burrows B. Predictors of mortality in chronic obstructive pulmonary disease. Am Rev Resp Dis 1979; 119: 895-902.
15. Rich S, Rubin L, Walker AM, Schneeweiss, Abenhaim L. Anoerxigens and pulmonary hypertension in the United States. Chest 2000; 117: 870-874.
16. Wanstall JC, Jeffery TK. Recognition and management of pulmonary hypertension. Drugs 1998; 56: 989-1007.
17. Ashutosh K, Phadke K, Fragale Jackson J, Steele D. Use of nitric oxide inhalation in chronic obstructive pulmonary disease. Thorax 2000; 55: 109-113.
18. Fuster V, Steele PM, Edwards WD, Gersh BJ, McGoon MD, Frye RL. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 1984; 70: 580-587.
19. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992; 327: 76-81.
20. Fartouk M, Humbert M, Capron F, et al. Severe pulmonary hypertension in histyiocitosis X. Am J Respir Crit Care Med 2000; 161: 216-223.
21. Olschewski H, Ghofrani A, Walmrath D, et al. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis. Am J Respir Crit Care Med 1999; 160: 600-607.
22. Farquharson CAJ, Struthers AD. Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure. Circulation 2000; 101: 594.
23. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Novick RJ. The registry of international society for heart and lung transplantation: fourteenth official report - 1997. J Heart Lung Transplant 1997; 16: 691-712.
24. Chaouat A, Weitzenblum E, Higenbottam T. The role of thrombosis in severe pulmonary hypertension. Eur Respir J 1996; 9: 356-363.
25. Rathburn SW, Raskob GE, Whitsett TL. Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systemic review. Ann Intern Med 2000; 132: 227-232.
26. Nicod P, Peterson KL, Levine MS, et al. Pulmonary angiography in severe pulmonary hypertension. Ann Int Med 1987; 107: 565-568.
27. Wolf M, Boyer-Neumann C, Parent F, et al. Thrombotic risk factors in pulmonary hypertension. Eur Respir J 2000; 15: 395-399.
28. Jamieson SW. Experience and results with 150 pulmonary thromboendarterectomy operations over a 29-month period. J Thorac Cardiovasc Surg 1993; 106: 116-127.
29. Fedullo PF, Moser KM. Advances in acute pulmonary embolism and chronic pulmonary hypertension. Advances in Internal Medicine. Mosby-Year Book Inc., 1997, vol 42.
30. Humbert M, Sitbon O, Simmoneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004; 351: 1425-1436.